Intranasal Insulin for Enhancement of Declarative Memory

Intranasal Insulin for Enhancement of Declarative Memory - Effects of Intranasal insulin on the declarative memory of healthy volunteers.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000025276

Enrollment

Registered

2017-06-30

Start date

2016-12-30

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy volunteers

Interventions

40 IU of intranasal regular insulin dissolved in 0.9% saline per day, in four divided doses, for four weeks. 0.9% saline (placebo) four times a day, for four weeks.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: students in institutes of higher education those that have been through higher education Age >18yrs

Exclusion criteria

Exclusion criteria: Any pre-existing medical condition

Design outcomes

Primary

Measure	Time frame
Enhancement of declerative memory in healthy individuals after 4 weeks of intranasal insulin treatment	—

Countries

Asia(except Japan)

Contacts

Public ContactOmar Abbas Ahmed Malik

Dow University of Health Sciences Dow Medical College

omar.a.a.malik@gmail.com00923362363569

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026